Sign in
4

Changes in Ownership

Olema Oncology, Inc. Filed Acc 0001415889-25-006158

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 205,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Zojwalla Naseem CHIEF MEDICAL OFFICER 2025-02-28 Grant or award · Stock Option (Right to Buy) +205,000 205,000 D
Loading xslF345X05/form4-03032025_090328.xml…